产品
编 号：F044043
分子式：C8H13N6O4P
分子量：288.2
分子式：C8H13N6O4P
分子量：288.2
产品类型
规格
价格
是否有货
1mg
询价
询价
5mg
询价
询价
10mg
询价
询价
25mg
询价
询价
50mg
询价
询价
100mg
询价
询价
结构图
CAS No: 113852-41-8
产品详情
生物活性：
PMEDAP is a potent inhibitor of human immunodeficiency virus (HIV) replication. PMEDAP has anti-murine cytomegalovirus (MCMV) activity. PMEDAP is a very potent inhibitor of Moloney murine sarcoma virus (MSV)-induced tumor formation and associated mortality.
体内研究：
PMEDAP (0.25-5 mg/kg; IP; daily; starting on the day of MSV-infected and continuing for an additional four days) causes a dose-dependent suppression of tumor formation and mortality in newborn mice inoculated with MSV.Animal Model:Three-week-old male NMRI mice
Dosage:0.25 mg/kg, 1 mg/kg, 5 mg/kg
Administration:IP; daily; starting on the day of infection and continuing for an additional four days
Result:Effected a significant delay in tumor appearance and an enhancement of the survival rate of tumor-bearing mice.
PMEDAP is a potent inhibitor of human immunodeficiency virus (HIV) replication. PMEDAP has anti-murine cytomegalovirus (MCMV) activity. PMEDAP is a very potent inhibitor of Moloney murine sarcoma virus (MSV)-induced tumor formation and associated mortality.
体内研究：
PMEDAP (0.25-5 mg/kg; IP; daily; starting on the day of MSV-infected and continuing for an additional four days) causes a dose-dependent suppression of tumor formation and mortality in newborn mice inoculated with MSV.Animal Model:Three-week-old male NMRI mice
Dosage:0.25 mg/kg, 1 mg/kg, 5 mg/kg
Administration:IP; daily; starting on the day of infection and continuing for an additional four days
Result:Effected a significant delay in tumor appearance and an enhancement of the survival rate of tumor-bearing mice.
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备